PIN1 and neoplasm: Therefore, most of the currently available inhibitors have been characterized as anticancer agents in various cancer cell lines and mouse models, with the primary aim of suppressing tumor growth and/or preventing tumor recurrence, as well as enhancing the understanding of Pin1 biology.